Arno Therapeutics

Arno Therapeutics

Specializing in converting 401k plans into Gold IRAs with expert guidance and reputable custodians.

HQ location
Parsippany-Troy Hills, United States
Launch date
Employees
Market cap
$178k
Enterprise value
($2m)
Share price
$0.00 ARNI
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round

$8.0m

Post IPO Equity
Total Funding000k
More about Arno Therapeutics
Made with AI
Edit

Arnothera operates in the financial services sector, focusing on retirement planning and investment strategies. The company primarily serves individuals looking to secure their financial future by converting their 401k plans into Gold IRAs. This niche market includes clients who are interested in diversifying their retirement portfolios with physical precious metals. Arnothera's business model revolves around providing detailed guidance and support throughout the conversion process, ensuring clients choose reputable custodians and understand the steps involved. The company generates revenue through advisory fees and commissions from partnering custodians. By offering a specialized service, Arnothera aims to provide financial security and peace of mind for its clients as they approach retirement.

Keywords: Gold IRA, 401k conversion, retirement planning, financial security, investment strategies, precious metals, custodians, advisory fees, niche market, portfolio diversification.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo